Viral Hepatitis

Due to the widespread infection of HCV and demand for these enhanced treatments, multiple estimates forecast the global market for HCV treatment will reach $20 billion yearly before the decade's get over.

Hepatitis is a medical condition defined by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organHepatitis A is an intense irresistible infection of the liver caused by the hepatitis A virus. Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects the liver. It can cause both intense and chronic infections. HCV is spread primarily by blood-to-blood contact connected with intravenous drug use, inadequately cleaned therapeutic gear, and transfusions.

    Related Conference of Viral Hepatitis

    March 18-19, 2024

    53rd World Congress on Microbiology

    Zurich, Switzerland
    May 09-10, 2024

    16th International Virology Summit

    Barcelona, Spain
    June 10-11, 2024

    5th International Conference on Molecular Microbiology

    Barcelona, Spain

    Viral Hepatitis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in